Elsa LaVita has grown her patient advocacy career rooted in rare disease and oncology. Elsa is the Director of Patient Advocacy at MorphoSys where she is responsible for ensuring the patient perspective is integrated into the development and commercialization of the company’s cancer medicines. She acts as the bridge between the company and patient communities. Elsa holds an MBA from Boston University and a BS from Cornell University.
